Novant Health Clinical Research provides access to a variety of cardiac research studies.
Twelve trials are currently active for this specific category
||VIRGO: Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients
||Amplatzer PFO Registry: CLOSURE OF PATENT FORAMEN OVALE With THE AMPLATZER® PFO OCCLUDER
||Prospective Multicenter Imaging Study for the Evaluation of Chest Pain
||Medtronic Shock-Less Study
||DN 03909; S-ICD System Clinical Investigation
||Celestial Post Approval Study
||A prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug-eluting stent (DES) or bare metal stent (BMS) placement
||A randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with elevated hsCRP.
||A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the six-month efficacy and safety of aliskiren therapy, on top of standard therapy, on morbidity and mortality when initiated early after hospitalization for acute decompensated heart failure.
||Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure.
||Rapid Extravascular Sealing via PercutanEous Collagen ImplanT
||VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndrome